Skip to content

A Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress in Healthy Adults

A Pilot Double-Blind Crossover Study on the Effects of VR-3 Herbal Blend Intake on Acute and Chronic Stress and Their Biomarkers in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00741962
Enrollment
20
Registered
2008-08-26
Start date
2008-08-31
Completion date
2009-04-30
Last updated
2009-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Brief summary

The purpose of this study is to determine the safety and efficacy of VR-3 Herbal Blend and its effects on acute and chronic stress responses.

Interventions

DIETARY_SUPPLEMENTVR-3 Herbal Blend

This is a liquid blend of various reputed adaptogenic herbs. The dosage will be 2ml of liquid per day.

DIETARY_SUPPLEMENTPlacebo

The placebo will be a similar tasting liquid as VR-3 Herbal blend. The dosage will be 2ml of liquid per day.

Sponsors

NEMA Research, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
35 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Men and women between the ages of 35-45 2. No health concerns as determined by study physicians 3. Women must not be pregnant or become pregnant for the duration of the study.

Exclusion criteria

1. The subject has a history of hypersensitivity to any of the compounds used in the study 2. The subject is pregnant or a lactating female. Note: If the potential subject is a post-menarcheal female, a pregnancy test (urine or serum) must be performed within 24 hours of study drug administration and confirmed negative in order for the potential subject to be enrolled). 3. History of Psychiatric Illness or Chronic Stress or Anxiety 4. Hypertension, cardiovascular disease, or other health concerns that may confound study results 5. Allergy or sensitivity to test product or ingredients 6. Individuals who are cognitively impaired or who are not able to give informed consent 7. Clinically significant or abnormal laboratory result that can confound the study 8. Medication or nutraceutical intake that can interact with the adaptogens or the biomarkers used in the study (to be determined by study physician) 9. Previous participation in a clinical research trial within 30 days prior to randomization 10. The subject has an ongoing abuse of illicit substances, alcohol, or actively smoking marijuana. 11. The subject is actively engaging in the use of Herbal Medicine, Traditional Chinese Medicine, Ancient Indian Medicine, Yoga, or Ayurveda

Design outcomes

Primary

MeasureTime frame
Change in salivary alpha-amylase and cortisol as stress biomarkers for the acute and chronic stress response following VR-3 Herbal Blend use10 weeks

Secondary

MeasureTime frame
Change in acute psychological stress10 weeks
Change in chronic stress10 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026